HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

RD3 0028

a benzodithiin compound effective against respiratory syncytial virus

Also Known As:

RD3-0028

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- RD3 0028: 2

Experts

1.	Konno, K: 1 article (01/2001)
2.	Shigeta, S: 1 article (01/2001)
3.	Sudo, K: 1 article (01/2001)
4.	Watanabe, W: 1 article (01/2001)
5.	Yokota, T: 1 article (01/2001)

Related Diseases

1.	Respiratory Syncytial Virus Infections 04/01/1999 - "We used a mouse model of RSV infection to determine the in vivo effect of RD3-0028. " 04/01/1999 - "Efficacy of RD3-0028 aerosol treatment against respiratory syncytial virus infection in immunosuppressed mice."
2.	Infections 01/01/2001 - "A time-dependent drug addition experiment indicated that the antiviral activity occurs in the late stage of the RSV replication cycle, since this compound completely inhibited syncytium formation even when added up to 16 hr after the infection of cell monolayers at an MOI of 3. RD3-0028 had no direct virucidal effect on RSV. "

Related Drugs and Biologics

1.	Aerosols
2.	Antiviral Agents (Antivirals)